Search clinical trials for: Influenza A

Total 495942 results

Celgene

Completed

Safety Study to Evaluate Immune Response of Vaccines in Participants With Relapsing Forms of Multiple Sclerosis Who Receive Ozanimod Compared to Non-Pegylated Interferon (IFN)-β or No Disease Modifying Therapy

Multiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting

United States, Germany
LumiraDx UK Limited

Suspended

Sample Collection Study to Aid Evaluation of an Influenza A/B, Respiratory Syncytial Virus & COVID-19 Virus POC Test (INFORM)

Covid19 | RSV Infection | Influenza Type B | Influenza Type A

United Kingdom
Osivax
Novotech (Australia) Pty Limited; Mater Misericordiae Limited

Completed

Immunogenicity and Safety of the Concomitant Administration of OVX836 Influenza Vaccine, Quadrivalent Inactivated Influenza Vaccines and Placebo in Healthy Subjects.

Influenza

Australia
LiteVax BV
University Hospital, Ghent

Completed

Safety, Tolerability, and Immunogenicity of TETRALITE, a Novel Adjuvanted, Low-dose Influenza Vaccin (TETRALITE-I)

Influenza

Belgium
University Hospital, Geneva
ModernaTX, Inc.; University of Geneva, Switzerland

Active, not recruiting

Mucosal Immunity: Influence on Infectious Viral Load: a Prospective Observational Study (MIViral)

SARS-CoV-2 Infection | RSV Infection | Influenza Viral Infections | Virus Shedding | Mucosal Immunity

Switzerland
IRCCS Policlinico S. Donato

Completed

Influenza A VIRus and Destabilization of Atherosclerotic Carotid Plaques (VIRAL)

Atherosclerosis

Italy
University of Southern California
University of California, Los Angeles; National Institute on Aging (NIA); Los...

Completed

Precision Vaccine Promotion in Underserved Populations

Influenza | Vaccine Hesitancy

United States
Janssen Vaccines & Prevention B.V.

Completed

A Study of Ad26.COV2.S and Influenza Vaccines in Healthy Adults

COVID-19 Prevention

United States, Belgium, Poland
Pensionsversicherungsanstalt

Completed

Development of a Research Agenda for Rehabilitation Research

Conditions Influencing Health Status | Research Agenda

Austria
MedImmune LLC
AstraZeneca

Suspended

A Case Control Study of the Effectiveness of Q/LAIV Versus Inactivated Influenza Vaccine and No Vaccine in Subjects 2-17 Years of Age (ICICLE)

Influenza Vaccine Effectiveness

United States, United Kingdom
Bristol-Myers Squibb

Completed

Study to Determine if the Flu Vaccine Increases the Risk of Muscle Damage in Participants Taking Drugs That Block Certain Proteins Made by Some Types of Immune System Cells

Cancer

United States
Sinovac Biotech Co., Ltd

Active, not recruiting

The Immunogenicity and Safety of the Booster Doses of a Live-attenuated Mumps Vaccine in Junior High School Students

Mumps | Influenza

China
Sanofi Pasteur, a Sanofi Company

Terminated

Study With Quadrivalent Recombinant Influenza Vaccine (RIV4) Compared With Egg-Based Quadrivalent Influenza Vaccine (IIV4) in Participants Aged 3 to 8 Years

Influenza Immunization

United States, Denmark, Poland, Spain
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Completed

Phase Ⅲ Clinical Study of Quadrivalent Influenza Virus Split Vaccine

Prevention of Influenza

China
National Institute of Neurological Disorders and...

Completed

HERV-K Suppression Using Antiretroviral Therapy in Volunteers With Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis

United States
Paolo Corradini
University of Milan

Completed

Immunologic Response After Pandemic Influenza A (H1N1) Vaccine in Onco- Hematologic Patients

Lymphoma | Multiple Myeloma | Myeloproliferative Disease

Italy
GlaxoSmithKline

Completed

Enhanced Safety Surveillance of GlaxoSmithKline's (GSK's) Quadrivalent Seasonal Influenza Vaccines During the 2018/19 Influenza Season

Influenza, Human

Germany, Spain, Belgium
National Institute of Allergy and Infectious Diseases...

Completed

Systems Analyses of the Immune Response to the Seasonal Influenza Vaccine

Healthy Volunteer

United States
Shanghai Institute Of Biological Products

Completed

A Clinical Trial of A Quadrivalent Influenza Vaccine

Influenza

China
Lizora LLC
Sheng'ai Traditional Chinese Medicine Hospital

Completed

Covid-19, Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) and Influenza Treatment System With Machine Learning

COVID-19 | Influenza | Post-COVID-19 Syndrome

China
Sanofi

Completed

Safety Surveillance of VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During the Influenza Season 2023/24

Influenza Immunization (Healthy Volunteers)

Finland, Germany
Ohio State University

Completed

Penetrating the Classroom Social Network for Children With Language Impairment Via Peer Mediated Intervention (PEERS)

Peer Influence

United States
Shanghai Institute Of Biological Products

Completed

Clinical Trial of Quadrivalent Influenza Virus Split Vaccine

Influenza

China
Oregon Health and Science University
Emory University; Ohio State University; University of Kentucky; University of...

Completed

The Peer-Based Retention of People Who Use Drugs in Rural Research (PROUD-R2)

Drug Use | Peer Influence

United States
ModernaTX, Inc.

Completed

Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA Vaccine Candidate Variations in Healthy Adults

Influenza

United States
ModernaTX, Inc.

Active, not recruiting

A Study of mRNA-1083 (SARS-Cov-2 and Influenza) Vaccine in Healthy Adult Participants, ≥50 Years of Age

Influenza | SARS-CoV-2

United States
Johns Hopkins Bloomberg School of Public Health
Merck Sharp & Dohme LLC

Completed

Immunogenicity of H. Influenzae Type b PRP-OMP Vaccines in American Indian and Alaska Native Children (the HibVax Study)

Haemophilus Influenzae Type B Infection

United States
Emergent BioSolutions

Completed

Universal Influenza A Vaccine in Healthy Adults (EBS-UFV-001)

Human Influenza

Australia
St. Jude Children's Research Hospital

Completed

A Pilot Study of Influenza Viruses Isolated From Immunocompromised Children and Adolescents

Influenza, Human

United States
The University of Hong Kong
Centers for Disease Control and Prevention

Active, not recruiting

Immunogenicity of Alternative Annual Influenza Vaccination Strategies in Older Adults in Hong Kong (PIVOT)

Influenza, Human

China
The University of Hong Kong
Centers for Disease Control and Prevention; Hospital Authority, Hong Kong

Active, not recruiting

Immunogenicity of Twice-annual Influenza Vaccination in Older Adults in Hong Kong (RETAIN)

Influenza, Human

China
The University of Hong Kong
National Institute of Allergy and Infectious Diseases (NIAID); University of...

Active, not recruiting

Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE)

Influenza, Human

Hong Kong
The Cooper Health System
Won Sook Chung Foundation

Completed

Vitamin D3 Supplementation to Prevent Respiratory Tract Infections

Respiratory Tract Infections | Covid19 | Flu Like Illness

United States
University of Oxford
Emory University; VisMederi srl

Completed

ADITEC FLU 2 STUDY: Understanding the Genetics Basis for Immune Responses to Flu Vaccines in Children and Adults

Influenza

United Kingdom
University of Bergen
Haukeland University Hospital

Active, not recruiting

Immune Response To Intranasal Influenza Vaccination

Tonsillitis, Hypertrophy

Norway
Universitat Jaume I

Completed

Feasibility of a Group Blended Transdiagnostic CBT Protocol for Emotional Disorders

Depressive Disorder | Anxiety Disorders

Spain
National Institute of Allergy and Infectious Diseases...

Completed

Influenza Challenge Study to Determine the Optimal Infection Dose and Safety of a Recombinant H3N2 (A/Texas/71/2017 (H3N2, Clade 3C3a) Influenza Strain

Influenza

United States
Sanofi Pasteur, a Sanofi Company

Completed

Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants

Pertussis Immunisation | Diphtheria Immunisation | Tetanus Immunisation | Pneumococcal Immunisation | Hepatitis B Immunisation | Haemophilus Influenzae Type b Immunisation | Polio Immunisation | Measles Immunisation | Rubella Immunisation | Varicella Immunisation | Mumps Immunisation

United States, Canada, Honduras, Puerto Rico
University of Southern Denmark
Odense University Hospital; Region of Southern Denmark; Odense Patient Data Explorative... and other collaborators

Completed

Advanced Point-of-care Technology During In-home Assessment Among Older Adults

Acute Illness | Acute Respiratory Disease

Denmark
University of St. Augustine for Health Sciences

Completed

Hormone Induced Effects on Ligament Laxity and Lower Extremity Motor Control

Hormone Influence on Ligament Laxity and Motor Control

United States
Begoña Quintana Villamandos
Baxter Healthcare Corporation

Completed

Desflurane vs. Sevoflurane in Endovascular Aortic Repair

Renal Failure

Spain
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID); National Institutes...

Withdrawn

Response to Live Attenuated Influenza Vaccine in Tonsillar Tissues and Blood (FLU-Tonsil)

Influenza

United States
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID); National Institutes...

Withdrawn

Response to Inactivated Influenza Vaccine in Lymph Tissue and Blood (FLU-LN)

Influenza

United States
Ab&b Biotechnology Co., Ltd.JS
Henan Center for Disease Control and Prevention

Completed

A Clinical Trial of an Quadrivalent Influenza Virus Subunit Vaccine in Chinese Children Aged 6 to 35 Months

Influenza

China
Pfizer

Completed

Safety and Immunogenicity of BNT162b2 Coadministered With SIIV in Adults 18 Through 64 Years of Age

COVID-19 | SARS-CoV-2 Infection

Australia, New Zealand
Biocad

Completed

A Study to Assess the PK, PD, Safety and Immunogenicity of Single IV Infusion of BCD-264 and Darzalex in Healthy Subjects

Healthy

Russian Federation
Centers for Disease Control and Prevention
University of Michigan; Rabin Medical Center; Soroka University Medical Center; Abt Associates and other collaborators

Completed

Immunogenicity Trial of Recombinant Influenza Vaccine Among HCP in Israel

Influenza

Israel
Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Completed

To Assess the Efficacy of GP681 Tablet Versus Placebo in Patients With Acute Uncomplicated Influenza Virus Infection

Influenza

China
Abbott Rapid Dx

Completed

Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Rapid Panel Professional Use Device and the Panbio™ COVID-19/Flu A&B Rapid Panel Self-Test Device

COVID-19 | Influenza A | Influenza Type B

United States
Vaxess Technologies
ICON plc; Q2 Solutions; Centricity Research

Completed

Phase 1 Evaluation of H1 Influenza Vaccine Delivered by MIMIX MAP

Influenza

Canada

Search clinical trials for: Influenza A

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hong Kong

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations